M. Kulyk & Associates, LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1842370
DECATUR, GA
Position in REGN
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$8,029,948
-$3,478,524 QoQ
Shares Held
12,878
-13.5% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
1.70%
of 13F equity value
Holder Rank
#326
of 1,322 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026M. Kulyk & Associates, LLC holds $8,296,692 across 2 Biotechnology names. REGN ranks #1 (96.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
12,878 | $8,029,948 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
537 | $266,744 |
All Filings in REGN
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,029,948 | 12,878 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $11,508,472 | 14,895 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $11,426,763 | 14,804 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $8,081,506 | 14,373 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $2,102,625 | 4,005 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $1,704,176 | 2,687 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $1,537,920 | 2,159 | Shares | Sole | 2025-02-07 | |
| No filing history on record for this holder in this stock. | ||||||